Ambiq (AMBQ) Q1 2026 earnings review
Edge AI Demand Fuels Revenue Acceleration, But Heavy Investments Delay Profitability
Ambiq delivered a massive top-line beat in Q1, with revenue growing 59% YoY to $25.1M, and guided Q2 even higher to $31.5M (midpoint), signaling accelerating 76% YoY growth. The core Apollo 5 platform and a new scaled global customer are driving this momentum across wearables and emerging IoT devices. However, the path to profitability remains distant. Operating expenses are surging—expected to hit $85M for the year—to fund aggressive Apollo 340 and Atomiq product roadmaps. With gross margins constrained around 45-46% by industry supply chain costs, management conceded that cash flow breakeven won't be reached until late 2027 or 2028, requiring roughly $47M in quarterly revenue.
🐂 Bull Case
Over 80% of units shipped in Q1 ran AI algorithms. With Q2 guidance implying ~76% YoY growth and strong second-half visibility, Ambiq's technology is clearly becoming a standard for ultra-low power edge computing.
Top 3 customer concentration dropped to 71% from 86% a year ago. Non-wearable revenue doubled YoY in Q1, proving the SPOT platform's viability in medical, industrial, and smart home markets.
🐻 Bear Case
To capture the AI opportunity, OpEx is guided to $85M in FY26. The company will need to nearly double its current record revenue run-rate (to ~$47M/quarter) just to reach breakeven.
Despite a mix shift to higher-value Apollo 5 chips and improved manufacturing yields, gross margins are guided flat (~45-46%) as third-party substrate and piece part costs offset internal efficiency gains.
⚖️ Verdict: ⚪
Neutral. The top-line acceleration and design win momentum are undeniably bullish, confirming Ambiq's technological moat. However, the rapidly escalating OpEx profile and capped gross margins mean investors must endure a multi-year cash burn phase before seeing operational leverage.
Key Themes
New Scaled Global Customer Ramping
A new major global customer officially entered mass production in Q1, driving the sharp sequential revenue jump. Management indicated this customer alone provides a significant baseline step-up, with accelerating volume expected to push Q2 revenue to the $31M-$32M range.
Apollo 5 Upgrade Cycle
Customers are actively migrating to the Apollo 5 architecture to support more complex AI workloads on-device. This platform scaling is driving both unit volume growth and providing an ASP uplift across the portfolio, which is critical for offsetting supply chain inflation.
End-Market Diversification Materializing
The strategic pivot beyond consumer smartwatches is yielding tangible results. Non-wearable pipeline now constitutes 25% of total opportunities. Q1 revenue from medical, industrial, and smart home sectors grew 100% YoY, and management expects this category to double for the full year 2026.
Gross Margin Headwinds Capping Profitability
Despite the bullish revenue narrative, profitability is being restrained. Non-GAAP gross margins printed at 46.2% in Q1, but management expects them to remain 'roughly flat' year-over-year. Internal yield improvements on the ramping Apollo 5 are being entirely negated by external industry dynamics—specifically rising substrate and piece part costs outside of Ambiq's control.
Surging OpEx Pushes Breakeven to 2028
The operational leverage story is broken in the near term. Non-GAAP OpEx jumped 38% YoY to $18.1M and is guided to $21.5M in Q2. Full-year OpEx is targeted at ~$85M (including $7M-$10M in IP purchases). The CFO explicitly noted the company needs ~$47M in quarterly revenue to break even—a level unlikely to be reached until late 2027 or 2028, contradicting the immediate 'profitability support' narrative.
Supply Constraints on Short-Lead Demand
While channel inventory remains lean, management admitted that the market is growing faster than expected, resulting in highly compressed lead-time requests from customers. Ambiq is currently leaving some demand on the table because it (and TSMC) cannot physically expedite material fast enough to meet these sudden spikes.
Macro: LLM Agents Pushing Compute to the Edge
The rise of LLM-driven AI agents is fundamentally shifting compute architectures. End customers are demanding real-time insights and faster response times without a round-trip to the cloud. This macro trend is accelerating the adoption of Ambiq's ultra-low power SPOT technology, making on-device intelligence viable in battery-constrained form factors.
Technology: The Atomiq and Apollo 340 Roadmaps
Ambiq is actively marketing its next-generation products. The Atomiq 110 (12nm process operating down to a record 300mV) remains on track for tape-out late this year, with initial ramps in late 2027. Meanwhile, Atomiq 120 is seeing strong Alpha interest for smart glasses, and the Apollo 340 is positioned to capture mass-market volume with sampling expected in 1H27.
Other KPIs
Accelerating. Up 56.2% YoY and up sequentially from $9.4M in 25Q4. While gross margin percentages are stuck in the mid-40s, the raw gross profit dollar generation is scaling beautifully with the top line.
A massive increase from $140.3M at the end of 2025, driven entirely by $76.8M in net proceeds from a follow-on offering. This zero-debt fortress balance sheet provides ample runway to absorb the projected $85M in FY26 operating expenses without immediate dilution risks.
Reversing. After bottoming out in late 2025 as part of a strategic pivot away from low-margin feature-neutral chips, China sales ticked up from 6.2% a year ago. Management clarified this growth is healthy, driven by customer programs utilizing higher-value Edge AI functionality rather than commodity parts.
Guidance
Accelerating. The midpoint of $31.5M represents a 76% YoY surge (compared to $17.9M in 25Q2) and massive 26% sequential growth. Driven by multiple overlapping customer product launch ramps.
Stable. The midpoint of 45.5% is down slightly from 46.2% in Q1. Represents the standoff between internal Apollo 5 yield improvements and external supply chain inflation.
Accelerating. Up sharply from $18.1M in Q1, reflecting $1.7M in planned IP purchases and structural scaling of engineering headcount to support upcoming tape-outs.
Stable to slightly Decelerating. The midpoint loss of $(0.26) is effectively flat with Q1's $(0.25) loss, as the massive gross profit dollar expansion is being entirely consumed by the $3.5M sequential jump in OpEx.
Accelerating. If 1H finishes with ~68% YoY growth, applying that to the second half implies full-year revenue well over $115M, easily tracking ahead of the company's prior 'path to $100M+' commentary.
Key Questions
Unfulfilled Demand Impact
You noted that you had to leave some demand on the table due to customers requesting lead times shorter than you or TSMC could support. Can you quantify how much revenue was missed in Q1 or pushed into Q2 due to these constraints?
Margin Pricing Strategy
With external substrate and piece part costs fully offsetting Apollo 5 yield improvements, to what extent are you implementing targeted price increases to protect gross margins, particularly for customers requesting emergency expedites?
Atomiq Tape-Out Milestones
The Atomiq 110 is scheduled for tape-out late this year with production in late 2027. Can you outline the specific technical or commercial milestones we should monitor over the next 12 months to gauge the success of this 12nm platform transition?